- letzte 200 News
- Archiv
| Zeit | Aktuelle Nachrichten | Rating | Leser | ||
|---|---|---|---|---|---|
| Do | ACRO Announces 2025 Officers and New Members | 189 | ACRO today announced that its Board of Directors elected Jim Reilly, Executive Vice President, Development Cloud Strategy at Veeva, as Chair of the Association, effective January 1, 2025. Cassandra... ► Artikel lesen | ||
| Do | Kao Corporation: Zur Nominierung von Kandidaten für die Position des Vorstandsmitglieds unseres Unternehmens | 257 | Der Vorstand und das Managementteam von Kao streben eine langfristige Steigerung des Unternehmenswerts auf der Grundlage unserer Geschäftsstrategie an. Um unseren Unternehmenswert zu steigern, sind... ► Artikel lesen | ||
| Do | Lamb Weston Reports Second Quarter Fiscal 2025 Results; Board Approves $250 Million Share Repurchase Authorization Increase and Increases Quarterly Dividend; Updates Fiscal Year 2025 Outlook | 16 | EAGLE, Idaho--(BUSINESS WIRE)--Lamb Weston Holdings, Inc. (NYSE: LW) announced today its results for the second quarter of fiscal 2025 and updated its full year financial targets for fiscal 2025.
"Our... ► Artikel lesen | ||
| Do | Regis Corporation Acquires Alline Salon Group Adding $83M Revenue and $5.8M EBITDA | 46 | MINNEAPOLIS--(BUSINESS WIRE)--Regis Corporation (NasdaqGM: RGS), a leader in the haircare industry, announces the acquisition of Alline Salon Group (ASG), its largest franchisee, in a transaction... ► Artikel lesen | ||
| Do | Vertex Announces Results From Phase 2 Study of Suzetrigine for the Treatment of Painful Lumbosacral Radiculopathy | 86 | BOSTON--(BUSINESS WIRE)--Vertex Pharmaceuticals Incorporated (Nasdaq: VRTX) today announced results from its Phase 2 study of suzetrigine, an investigational, oral, highly selective NaV1.8 pain... ► Artikel lesen | ||
| Do | A Phase 3 Ready DMD Gene Therapy, a Clinical Trial to Offset AAV Neutralizing Antibodies, and an AI Inspired New Generation of Capsids Highlight Genethon's 2024 Fall Milestones | 194 | Genethon, a unique non-profit gene therapy R&D organization founded by the French Muscular Dystrophy Association (AFM-Telethon), achieved several major clinical development and scientific milestones... ► Artikel lesen | ||
| Do | Dong-A ST CO., Ltd: Dong-A ST sichert Zulassung für das Stelara-Biosimilar IMULDOSA in Europa | 205 | - Globale Marktexpansion beschleunigt sich durch aufeinanderfolgende FDA- und EC-Zulassungen Dong-A ST (CEO: Jeong Jae-hoon, KRX: 170900) gibt bekannt, dass sein Stelara-Biosimilar IMULDOSA (Projektname:... ► Artikel lesen | ||
| Do | Arverne Group Announces the Completion, by Its Subsidiary 2gré, of Its First 3D Subsurface Exploration Campaign in the Auvergne-Rhône-Alpes region | 238 | Regulatory News:
Arverne Group (FR001400JWR8, ARVEN), a French industrial company specializing in the production of renewable energy from underground resources to support the energy transition... ► Artikel lesen | ||
| Do | Valnet Inc.: GIVEMESPORT Signs World-Renowned Transfer Insider Fabrizio Romano to Join its Football Coverage | 204 | GIVEMESPORT.com, a Valnet Inc. publication and leader in delivering high-quality football content in the digital media space, is thrilled to announce the addition of world-renowned transfer insider... ► Artikel lesen | ||
| Do | Energy Dome und ENGIE unterzeichnen bahnbrechende Vereinbarung zur Speicherabnahme | 306 | Diese Vereinbarung unterstreicht das gemeinsame Engagement von ENGIE und Energy Dome für die Förderung von Langzeit-Energiespeicherlösungen und stellt einen wichtigen Meilenstein bei der kommerziellen... ► Artikel lesen | ||
| Do | Energy Dome and ENGIE Sign Pioneering Storage Offtake Agreement | 300 | This agreement highlights the shared commitment of ENGIE and Energy Dome to advancing long-duration energy storage solutions, marking a significant milestone in the commercial deployment of innovative... ► Artikel lesen | ||
| Do | Information Services Group, Inc.: Ukraine Conflict Impacting Nordics Cloud Adoption | 212 | Supply chain disruptions and skilled labor shortages are intensifying enterprise demands for better business value in the short term, ISG Provider Lens report says
The conflict in Ukraine has intensified... ► Artikel lesen | ||
| Do | Groupe SEB: French Competition Authority Inquiry | 258 | Regulatory News:
Groupe SEB (Paris:SK) acknowledges the press release published by the French Competition Authority on December 19, 2024, with respect to an inquiry launched in October 2013, into... ► Artikel lesen | ||
| Do | KAYTUS-NextGen-Server: Starke Leistung für die KI-Ära mit moderner Flüssigkeitskühlung | 180 | Die V3-Server von KAYTUS demonstrieren die durchgängige Kompetenz des Unternehmens bei Flüssigkeitskühllösungen-einschließlich umfassender Forschung und Entwicklung, Produktion, Testen und Lieferung-und... ► Artikel lesen | ||
| Do | Skechers U.S.A., Inc.: New Skechers Concept Store Opens in Prague | 229 | The Company's Centrally-Located Retail Destination on Na Príkope Street will Expand its Presence Among Locals and Tourists in the Czech Republic
Skechers announced that The Comfort Technology Company... ► Artikel lesen | ||
| Do | Dong-A ST CO., Ltd: Dong-A ST Secures European Approval for Stelara Biosimilar IMULDOSA | 357 | - Global Market Expansion Accelerates with Back-to-Back FDA and EC Authorizations Dong-A ST (CEO: Jeong Jae-hoon, KRX: 170900) proudly announces that its Stelara biosimilar, IMULDOSA (Project... ► Artikel lesen | ||
| Do | ASTRA 1P Starts Delivering Content Across Europe | 205 | Most powerful satellite to operate at SES's prime TV neighbourhood of 19.2 degrees East will deliver content to 118 million TV homes
SES announced today that ASTRA 1P, the company's most advanced... ► Artikel lesen | ||
| Do | Sangamo Therapeutics, Inc.: Sangamo Therapeutics and Astellas Announce Capsid License Agreement to Deliver Genomic Medicines for Neurological Diseases | 338 | Agreement grants Astellas rights to employ Sangamo's novel proprietary capsid, STAC-BBB, for up to five potential neurological disease targets
Sangamo to receive a $20 million upfront license fee... ► Artikel lesen | ||
| Do | Palliser Capital Announces Submission of Resolution to Rio Tinto Calling for Independent Review on Unifying Dual Listing | 404 | Resolution will provide shareholders full visibility into independent, comprehensive, and transparent analysis on merits of unification Open letter to the Board highlights c.$50 billion... ► Artikel lesen | ||
| Do | Best Marktsegment-Bericht: Der Ausblick von AM Best für das deutsche Schaden- und Unfallversicherungs-Segment bleibt negativ | 169 | AM Best behält seinen negativen Ausblick für das deutsche Schaden- und Unfallversicherungs-Segment bei.
In dem neuen Best's Market Segment Report "Market Segment Outlook: Germany Non-Life Insurance"... ► Artikel lesen | ||
| Do | Thales verbessert den Fahrzeugzugang mit zuverlässigen und sicheren kontaktlosen Lösungen | 259 | Die Akteure der Automobilindustrie können sich darauf verlassen, dass Thales digitale und physische Lösungen bereitstellt, die den Fahrzeugzugang verbessern und gleichzeitig die Datensicherheit... ► Artikel lesen | ||
| Do | Thales to Enhance Vehicle Access With Reliable and Secure Contactless Solutions | 196 | Car industry players can rely on Thales to provide digital and physical solutions that improve car access experiences, while ensuring data security
Thales's offer encompasses a digital car... ► Artikel lesen | ||
| Do | Antin Infrastructure Partners Closes Flagship Fund V Above €10 Billion Target | 358 | The new fund is expected to be the largest infrastructure fund to hold a final closing worldwide in 2024
Regulatory News:
Antin Infrastructure Partners (Paris:ANTIN), one of the world's leading... ► Artikel lesen | ||
| Do | Selbstpflege für die Haut: Das ultimative Weihnachtsgeschenk von Quanta System | 218 | Steigern Sie Ihr Selbstvertrauen und erleben Sie die Kraft der personalisierten Laser-Hautpflege mit der Chrome Lase-Station® für eine gesündere, strahlende Haut
Die Weihnachtszeit ist der perfekte... ► Artikel lesen | ||
| Do | Prothena Corporation plc: Roche's Phase IIb Study of Prasinezumab Missed Primary Endpoint, But Suggests Possible Clinical Benefit in Early-Stage Parkinson's Disease | 327 | PADOVA study showed numerical delay in motor progression and positive trends on multiple secondary and exploratory endpoints
Prasinezumab continues to be well tolerated and no new safety... ► Artikel lesen |
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und .
